RHEUMATOLOGY
Treat-to-Target Rheumatology Without the Biologic Paperwork Drag
GlaceEMR and GlaceRCM built for disease-activity scoring, DMARD monitoring, biologic prior auth, and infusion-day J-code billing, charged at a percentage of collections with no base fees and backed by 95%+ first-pass claim adjudication and 99%+ collection of payer-allowed amounts*.
*Of payer-allowed amounts.
WHAT WE HEAR FROM RHEUMATOLOGISTS
The Chart Was Built for Somebody Else’s Visit
Rheumatology is a treat-to-target specialty, and most EHRs were built for a single acute visit. The chart buckles the moment you carry disease-activity scoring, relentless DMARD monitoring, biologic prior auths, and infusion-day J-code billing. Four pains come up in the first thirty minutes of almost every discovery call.
Biologic prior auths take days
Every new start and step-therapy fail runs through a payer auth queue on its own schedule. Patients flare while paperwork sits, and your nurses run it between rooming patients.
Disease scores live outside the chart
RAPID3, DAS28, CDAI, and BASDAI calculated on paper and dropped into free text, never trended. The line that justifies escalating a biologic is the one that never gets drawn.
DMARD monitoring slips
Methotrexate CBC and LFTs, TPMT, the hydroxychloroquine eye exam. The horizontal EMR enforces none of it, the nurse’s spreadsheet falls behind, and a transaminitis becomes your liability.
Infusion revenue leaks at the chair
Without an infusion log in the chart, units and times get rebuilt from memory, JW and JZ wastage modifiers get missed, and J-code dollars leak straight off the bottom line.
GLACEEMR FOR RHEUMATOLOGY
An EHR Built Around Treat-to-Target
GlaceEMR is ONC-certified and has run in private rheumatology practices for years, with 30+ years of company history behind it. The rheumatology configuration is wired in before training starts, so disease-activity scoring, DMARD monitoring, joint mapping, biologic tracking, and infusion documentation are switched on from the first login.
Disease-activity scoring in the record
DAS28 (CRP and ESR), CDAI, SDAI, DAPSA, BASDAI, ASDAS, RAPID3, and SLEDAI calculated from structured visit data and trended visit to visit. The remission target is visible at a glance, so the treat-to-target conversation runs on a real line, not on memory.
Biologic tracker per patient
One panel per patient: drug, dose, route, last-given and next-due dates, lot number, infusion site, and prior-auth status. Your scheduler sees who needs an infusion next week, and your billing team sees which auths expire next month, without opening five charts.
Pre-biologic clearance templates
One template gathers TB testing (quantiferon or PPD), hep B and hep C serology, vaccination status, and clearance documentation. The chart shows green when the patient is cleared to start or restart, so the infusion that would have been postponed runs on time.
DMARD monitoring engine
Methotrexate, leflunomide, hydroxychloroquine, azathioprine, and the JAK inhibitors carry their monitoring cadence in the chart. CBC, LFTs, and CrCl trend with safety flags, and ocular surveillance scheduling is built in, so a missed lab is a flag rather than a liability.
In-office infusion logs
Capture drug, dose, units administered, units wasted, start and stop times, premeds, and reaction notes at the chair. The log feeds the J-code claim with the right administration code, the right wastage modifier, and the NDC unit math handled before the encounter closes.
Joint exam, homunculus, and imaging
Structured 28-joint and 66/68-joint counts feed the activity calculators automatically, with a joint homunculus for mapping. MSK ultrasound, hand and foot films, and DEXA read in the chart through the integrated PACS viewer, with no separate viewer to launch.
Included with GlaceEMR vs usually an add-on
When you price out another EMR, count what is included before you compare the headline number. The rows below are upsells or separate vendors almost everywhere else, each with its own renewal date and price increase. They ship with GlaceEMR, with no tier games at renewal.
| Capability | Most EMRs | GlaceEMR |
|---|---|---|
| PACS and DICOM viewer for MSK ultrasound, films, DEXA | Add-on license | Included |
| CCM, RPM, and PCM for between-infusion touchpoints | Separate product | Included |
| Self-check-in kiosk with RAPID3 PROMs, English and Spanish | Third-party vendor | Included |
| 200+ reports plus a self-serve report builder | Consulting or ticket | Included |
| GlaceOffice administration suite (HR, PTO, inventory) | Separate subscription | Included, free for clients |
| Native iOS and Android apps for providers and infusion staff | Mobile-web only | Included |
A solo rheumatologist can grow to a multi-provider group across locations and infusion suites on the same platform, with no per-location upcharge and no contract to renegotiate when you add a satellite suite next quarter.
FROM CHAIR TO PAID
The Infusion Day, Tracked End to End
GlaceIQ assembles the prior-auth packet for your review, the clearance template confirms the patient is safe to start, the chair-side log captures units and wastage, the scrubber checks the J-code claim against payer rules before it goes out, and your named billing specialist works it to resolution. One chart and one team carry the dollar from the chair to the deposit, so nothing falls through a handoff between four vendors.
GLACERCM FOR RHEUMATOLOGY
A Billing Team That Knows Biologics, J-Codes, and Prior Auth
GlaceRCM bills your claims in your EMR or ours, charged at a percentage of collections with no base fees and no monthly minimums. We would rather run it on our platform, where the scrubber reads the infusion log directly, but if you are staying on your EMR our team works your claims there. The service is built for the prior-auth-heavy, infusion-heavy rheumatology payer panel.
95%+
First-pass claim adjudication. Most claims, including infusion-day J-code claims, pay on the first submission, with no rework and no calendar lost to denial follow-up.
99%+
Collection rate of payer-allowed amounts*. The dollars the payer contractually owes you arrive, because we work the queue to resolution instead of writing it off at 90 days.
$0
Implementation fee, setup charge, and monthly minimum. We get paid when you get paid, so our interests and yours line up from the day the contract is signed.
*Of payer-allowed amounts.
Biologic prior authorization as a service
Biologic and JAK-inhibitor auths assembled with the packet payers actually need: diagnosis, prior failed therapies, disease-activity scores, TB and hep clearance, and step-therapy attestations. We follow each auth to decision, including the peer-to-peer, so your nurses stop running auth between rooming patients.
J-code infusion billing tuned to the chair
The scrubber reads the infusion log and assembles J-codes correctly: originator versus biosimilar Q-codes, JW and JZ wastage modifiers, NDC unit math, and the administration codes (96365, 96413, 96415) that go with them. Buy-and-bill versus white-bagged routing is flagged at the chair, not rebuilt at end of day.
Denials worked to resolution
Step-therapy, medical-necessity, dose-frequency, and NOC-code denials get worked, not written off. Appeals are assembled with disease-activity scores and prior failed-therapy documentation. The write-off only happens when you sign off, and the dashboard shows where every disputed dollar stands.
A named billing specialist
A dedicated account manager who knows rheumatology payer mix in your state, the J-codes you bill, the biosimilar substitution rules in your top plans, and your top denials. Not a ticket queue, not an offshore call center. They know your practice by name within a month of go-live.
Percentage of collections, no base fees. Provider credentialing, payer enrollment, specialty-pharmacy and copay-assistance coordination, daily patient statements, and a US-based billing call center are part of the service, not separate line items. Your patients call our team about an infusion-day balance, not your front desk, so the receptionist confirming tomorrow’s chair schedule is not stuck on a billing call.
AI AND PATIENT ENGAGEMENT
The Documentation, the Coding, and the Phones
Every AI capability is a suggestion you review and select. Notes wait for your signature and codes wait for your approval before either reaches a claim, so the coding judgment and the clinical decision stay with you. The AI is built on HIPAA-compliant infrastructure from Amazon, Google, Anthropic, Deepgram, ElevenLabs, and other enterprise AI providers, with multi-vendor architecture that preserves operational redundancy.
GlaceScribe
Ambient SOAP notes structured the way rheumatology writes, with joint-count-driven HPI, disease-activity assessment folded in, and a plan organized by therapy. It recognizes ACR criteria language and DMARD titration phrasing. Up to four speakers, in person or telehealth, English and Spanish patient-facing.
GlaceIQ
30+ AI features tuned to your day: pre-charting from the disease-activity trend, activity-change flags before a flare, AI-assembled prior-auth packets, DMARD refill safety prompts, and per-J-code reimbursement at charge entry. You review and select each suggestion.
GlacePhoneSmart
An AI phone agent answers as your practice in English or Spanish, books into real chair and visit slots, runs infusion-day confirmations and biologic refill reminders, fills cancellations, and surfaces voicemail summaries so the front desk stops drowning during biologic season.
A practice-branded portal, mobile app, kiosk, SMS, and email round out the stack, with English and Spanish on every patient-facing surface. RAPID3 pushes pre-arrival and lands in the chart as structured data, monthly methotrexate lab-due nudges and hydroxychloroquine eye-exam recalls go out on the cadence the care plan calls for, and replies route back into the chart as structured tasks instead of piling up in an inbox somebody reads on Monday.
SWITCHING IS EASIER THAN YOU THINK
Coming From Another EMR
Most rheumatology practices we onboard are leaving a legacy platform that never fit the infusion load. The transition is the part you dread most, and it is the part we have done hundreds of times. Implementation is $0, data migration is included, and your account manager runs the move and stays your account manager after go-live.
DAY 1
A chart that already looks like yours
You log in to migrated history, active problem lists, current biologic and DMARD regimens, monitoring trends, and clearance documentation, with your templates, order sets, disease-activity calculators, and infusion-log layout already wired in. EMR go-live happens in under one week. By the end of the day your hands start to remember where everything lives.
DAY 30
Charting faster, claims flowing
You are charting faster than on the old system because the templates match how you document, and GlaceScribe carries most of your HPIs. Your first month of infusion-day claims is on the dashboard, your first biologic auths have been worked end to end, and your DMARD monitoring outliers surface as a real worklist instead of living in a nurse’s head.
DAY 90
The switch starts paying for itself
Your first quarter’s dashboard shows cleaner infusion-day claims, faster posting, fewer denials in the 60-to-90 bucket, and biosimilar substitution rules running correctly. Hydroxychloroquine surveillance stops slipping, the pre-biologic clearance queue empties by Friday, and the conversation turns from migration triage to using the platform harder next quarter.
Data migration covers historical records, DMARD and biologic history, monitoring lab trending, clearance documentation, allergies, and outstanding orders, handled by Glenwood from your prior vendor’s data export in 2 to 5 business days. The RCM transition runs 4 to 8 weeks with payer enrollment in parallel, and we recommend a 30-to-90-day overlap with your previous vendor so active biologic regimens never get interrupted. Glenwood has been independent and privately held since 1994: 30+ years in market, no outside investors. Support runs 7:00 AM to 8:00 PM Eastern on weekdays, with 24×7 on-call coverage for urgent issues, so the practice with an infusion-day issue at 6:30 AM Pacific still reaches a person.
WE KNOW YOUR CODES
We Have Billed Your Mix Before
You already know your codes. We have built the workflows, the scrubber rules, the documentation prompts, and the denial templates around them, so the reimbursement you earned is the reimbursement you collect. The list below is the short version of what runs every day inside the platform for a rheumatology practice:
- 99213, 99214, 99215: office E&M, established rheumatology follow-up
- 96365, 96366: therapeutic IV infusion, initial and additional hours
- 96413, 96415: complex biologic infusion, initial and additional hours
- 96372: therapeutic injection for in-office biologic dosing
- 20610, 20611: major joint aspiration or injection, without and with ultrasound
- J1745, Q5103, Q5104, Q5121: infliximab originator plus biosimilar Q-codes, with JW/JZ wastage handled
- J3490, J9999: unclassified drug codes when a payer has not loaded the agent
- G2212: prolonged service add-on for the complex management visit past 99215
QUESTIONS WE HEAR EVERY WEEK
Rheumatology Practice FAQ
Short answers below; the longer conversation happens on the demo. Tap any question to expand the answer.
Does GlaceEMR handle disease-activity scoring as structured data?
Yes. RAPID3, DAS28 (CRP and ESR), CDAI, SDAI, DAPSA, BASDAI, ASDAS, and SLEDAI are captured as discrete fields and trended visit to visit. The tender and swollen joint counts from the exam feed the calculators automatically, so the score is generated from the structured data you already entered, not transcribed into free text nobody can trend later. The remission target is visible on the trend graph at the moment of the visit, the treat-to-target conversation runs on a real line, and the documentation you need to defend escalating a biologic at audit is a byproduct of how you charted. RAPID3 also arrives pre-populated from the portal questionnaire your patient completed before walking in.
How does GlaceRCM handle biologic prior authorization?
GlaceIQ assembles the documentation packet from the chart: diagnosis, prior failed agents, disease-activity scores, TB and hep clearance, vaccination history, and step-therapy attestations. Our billing team finishes, validates, and submits, follows the auth through to decision, and schedules the peer-to-peer when medical necessity is in dispute. The 45-minute manual project shrinks to a five-minute review for the prescriber. Pricing is per authorization with no monthly minimum, included inside the GlaceRCM service for practices on the bundled contract. Your nurses stop running prior auth between rooming patients, and the renewal calendar runs as a managed program inside the same dashboard that runs your denials and collections.
Is GlaceScribe HIPAA-compliant, and where does the AI run?
Yes, fully HIPAA-compliant. GlaceScribe runs on HIPAA-compliant AI infrastructure from Amazon, Google, Anthropic, Deepgram, ElevenLabs, and other enterprise AI providers, all under business associate agreements. The multi-vendor architecture preserves operational redundancy, so a single upstream incident does not stop your visits. Up to four simultaneous speakers are supported, English and Spanish patient-facing, and all coding and order suggestions surface for your review before any signing. Nothing reaches the chart until you approve it. Audio is processed in transit, the resulting note is stored in your single-tenant chart database with LUKS encryption at rest, and the data never trains a shared model that mixes your patients with anybody else’s.
What does GlaceRCM pricing actually look like, and can we keep our EMR?
You pay a percentage of what we collect, with no base fees, no implementation charges, and no monthly minimums. The exact percentage depends on your code mix, payer panel, infusion volume, and overall volume, and you will have it after a 20-minute discovery call. We would rather run the full bundle, where the billing quality depends on the scrubber reading the chart and infusion log directly, and about 98% of Glenwood clients choose that path. But we are flexible: if you want to keep your current EMR, our billing team will work your claims in your EMR or ours. You will not see surprise line items for credentialing, denial follow-up, prior auth, statements, or the call center your patients use, because all of that is part of the service.
How long is implementation, and what does training look like for an infusion practice?
You go live on the EMR in under a week. Your RCM transition runs 4 to 8 weeks alongside payer enrollment. We handle your data migration in 2 to 5 business days, including DMARD and biologic history, monitoring lab trending, and clearance documentation, so your staff does not have to clean charts. Providers and infusion nurses train in pieces around real clinic, not in a multi-day block that forces you to close the chair: a 2-to-4-hour core clinical session, then targeted follow-ups for advanced modules and the infusion-log workflow. Every role gets unlimited online training during onboarding, and it stays available for new hires later. We recommend keeping your previous vendor running alongside us for 30 to 90 days so active biologic regimens never get interrupted, and the account manager who runs your migration is the same one who picks up the phone in month six.
“[Specialty-specific testimonial quote, replace with verified Rheumatology physician quote or remove this card.]”
[Physician Name, MD]
[State]
If you carry adjacent panels, see how GlaceEMR runs internal medicine, endocrinology, nephrology, and orthopedics.
See What Glenwood Can Do for Your Practice
A 20-minute working call. We show you the platform on your specialty’s actual workflows, not a generic demo.